Translations:Discovery and development of angiotensin receptor blockers/42/en
Jump to navigation
Jump to search
All of the ARBs have the same mechanism of action and differences in their potency can be related to their different pharmacokinetic profiles. A few clinical head-to-head comparisons have been made and candesartan, irbesartan and telmisartan appear to be slightly more effective than losartan in lowering blood pressure. This difference may be related to different strengths of activity at the receptor level, such as duration and strength of receptor binding.